Glenmark Launches Multi-Country Phase 3 Trial of Envafolimab in Stage III NSCLC Patients
Glenmark Pharmaceuticals Ltd., a global research-driven pharmaceutical company, has initiated a multi-country Phase 3 clinical trial of Envafolimab, a first-in-class […]
